Skip to content

MURIM: MUltidisciplinary Research on Implantation failure and Miscarriage

MURIM: MUltidisciplinary Research on Implantation failure and Miscarriage - MURIM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56176
Enrollment
249
Registered
2018-12-31
Start date
2019-04-09
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility Subfertility

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Repeated implantation failure - Female aged 18-38 years old - Repeated implantation failure (RIF) defined as: - failure of implantation of three high quality embryo*s or after placement of ten or more embryo*s in multiple transfers - Primary or secondary infertility - Written informed consent Recurrent miscarriages - Female aged 18-38 years old - Repeated, unexplained miscarriages (RM) defined as 2 or more unexplained miscarriages not caused by abnormal parental karyotype, maternal thrombophilia and/or uterine abnormalities - Written informed consent Control - Female aged 18-38 years old - Uneventful previous pregnancy defined as no preterm delivery, pre-eclampsia or fetal growth restriction and live birth OR presumed fertile defined as an indication for PESA/TESE, female sterilisation, or PGD indication for genetic analysis without subfertility treatment - Written informed consent

Exclusion criteria

Exclusion criteria: Repeated implantation failure - Clinically relevant intra-uterine pathology - BMI > 35 kg/m2 - Untreated endocrine abnormalities - PGD treatment Recurrent miscarriages - Current or recent ( 35 kg/m2 Control group - Recurrent miscarriages or repeated implantation failure - Current or recent ( 35 kg/m2 - Severe endometriosis (3th -4th degree)

Design outcomes

Primary

MeasureTime frame
The main study parameters are steroid profile in endometrial tissue and serum, activity of steroid enzymes, phenotype and function of Natural Killer cells, presence of HLA antibodies, determination of the vaginal microbiome and volatile organic compounds.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026